Catalyst Wire Dossier Catalyst Wire Dossier

Lenavatinib

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenavatinib, covering 2023-06-13 to 2023-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients [Phase 2]

See pricing